Amgen, Onyx stocks react to report of $130 a share takeover
This article was originally published in Scrip
Executive Summary
Shares of Amgen jumped and Onyx Pharmaceuticals’ stock dropped on a report that a takeover deal may be struck soon for around $130 a share, a lower price than many investors hoped.